Kyle Smith is President & COO of Aprecia Pharmaceuticals, where he leads strategic operations and innovation in 3D-printed drug manufacturing. With over a decade at Aprecia, he’s held roles from Operations Engineer to VP of Operations, driving advancements in pharmaceutical technology and GMP compliance. He also serves on the Board of Directors at BAMF Health, a leader in cancer imaging and theranostics. Kyle holds a Chemical Engineering degree from Georgia Tech and an MBA from Miami University.